J L Anderton, P Kincaid-Smith. Show Affiliations »
Abstract
Mesh: See more » Administration, OralAminophylline/adverse effectsAscites/drug therapyCalcium/urineCarbohydrate MetabolismCarbonic Anhydrase Inhibitors/adverse effectsDiabetes Insipidus/drug therapyDiuretics/administration & dosageDiuretics/adverse effectsDiuretics/pharmacologyDiuretics/therapeutic useEdema/drug therapyEthacrynic Acid/adverse effectsFemaleFurosemide/adverse effectsHeart Failure/drug therapyHumansHypertension/drug therapyHypokalemia/chemically inducedHyponatremia/chemically inducedInjections, IntravenousKidney Failure, Chronic/drug therapyLiver Cirrhosis/complicationsMannitol/adverse effectsNatriuresis/drug effectsNephrotic Syndrome/drug therapyOrganomercury Compounds/adverse effectsOrganomercury Compounds/therapeutic usePoisoning/drug therapyPre-Eclampsia/drug therapyPregnancySpironolactone/adverse effectsTriamterene/adverse effectsUric Acid/metabolism
Substances: See more » Carbonic Anhydrase InhibitorsDiureticsOrganomercury CompoundsUric AcidSpironolactoneAminophyllineMannitolFurosemideEthacrynic AcidCalciumTriamterene
Year: 1971 PMID: 4939014 DOI: 10.2165/00003495-197101020-00003
Source DB: PubMed Journal: Drugs ISSN: 0012-6667 Impact factor: 9.546